At a glance
ClinicalIndex Comparison RecordN/ACompleted· 237 enrolled
Drug / intervention
InflammaDrydevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye
In Brief
An observational study evaluating InflammaDry for Dysfunctional Tear Syndrome. Completed, enrolled 237 participants across 4 sites.
Detailed Summary
InflammaDry is a rapid diagnostic test for the detection of elevated levels of Matrix Metalloproteinase-9 (MMP-9) protein in tear fluid.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDysfunctional Tear Syndrome
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedSep 2012
Enrollment StartOct 2012
Primary CompletionMay 2013
TodayJul 2026
First PostedSep 26, 2012
Enrollment StartOct 1, 2012
Primary CompletionMay 1, 2013
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 13.8 years ago
Interventions
InflammaDrydevice
A noninvasive immunoassay for detecting MMP-9 levels in tears.